GJA1 and Parkinson disease: Moreover, inhibition of Cx43‐based HCs activity ameliorates neuroinflammation and degeneration of dopaminergic neurons in preclinical models of PD mediated by intranigral lipopolysaccharide injection (Zhao et al. 2022).